Legislative Advocacy
- ASHP Statement to the Senate Committee on Health, Education, Labor, and Pensions: "Managing Pain During the Opioid Crisis"
- Issue Brief: H.R. 6 - SUPPORT for Patients and Communities Act
- ASHP Urges Senate to Pass Opioid Bill Containing Key Provisions
- ASHP Submits Letter to Leaders of the Energy and Commerce Health Subcommittee on Pharmacists Role in Managing the Opioid Crisis
- ASHP Submits Policy Recommendations on Ways to Improve Response to Opioid Epidemic
- ASHP Joins Others in Statement for the Record: “Federal Efforts To Combat The Opioid Crisis: A Status Update On Cara And Other Initiatives”
Regulatory Activity
- Issue Brief: HHS Loosens X-waiver Training Requirement for Clinicians Treating Fewer than 30 Patients
- ASHP Letter to HHS Assistant Sec for Health on Elimination of X-Waiver Requirements [PDF]
- Opioid Task Force Submits Joint Letter on the Proposed Annual Production Quotas [10/15/19]
- ASHP Submits Comments to HHS Request for Information on CIIs
- ASHP Recommends Development of Interprofessional Education Regarding Opioids [PDF]
- ASHP Submits Comments on CDC’s Draft Prescribing Guidelines for Opioids
- ASHP Comments on FDA Development and Regulation of Abuse Deterrent Formulations of Opioids [PDF]
- ASHP Expresses Concern that Overly Restrictive Labeling for Opioids Could Limit Patient Care [PDF]
